Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | XBP1 | P17861 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | CSF1R | P07333 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.50 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.49 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4276707 | 0.90 | TSHR (0.54) | ALDH1A1HPGDCYP1A2CYP2C19XBP1 | |
| SCHEMBL20806394 | 0.89 | ALDH1A1 (0.49) | ALDH1A1HPGDCYP1A2CYP2C19XBP1 | |
| SCHEMBL20806416 | 0.88 | CYP1A2 (0.48) | ALDH1A1HPGDCYP1A2CYP2C19XBP1 | |
| SCHEMBL20806415 | 0.86 | CYP1A2 (0.53) | ALDH1A1HPGDCYP1A2CYP2C19XBP1 | |
| SCHEMBL24685127 | 0.86 | ALDH1A1 (0.46) | ALDH1A1HPGDCYP1A2CYP2C19XBP1 | |
| SCHEMBL20799747 | 0.85 | GABRA2 (0.50) | ALDH1A1HPGDCYP1A2CYP2C19XBP1 | |
| SCHEMBL4830396 | 0.84 | TSHR (0.63) | ALDH1A1HPGDCYP1A2CYP2C19TSHR | |
| SCHEMBL20806393 | 0.84 | TSHR (0.51) | ALDH1A1HPGDCYP1A2CYP2C19XBP1 | |
| SCHEMBL18143540 | 0.84 | CA12 (0.62) | ALDH1A1HPGDTSHRSMN1; SMN2MAPT | |
| SCHEMBL28740395 | 0.84 | TSHR (0.54) | ALDH1A1HPGDCYP1A2TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10472313-B1 | Process for synthesizing trifluoroketones | GRAPHENE 3D LAB INC. (US) | 2019-11-12 | — | — | US | disclosed |
| US-10472313-B1 | Process for synthesizing trifluoroketones | GRAPHENE 3D LAB INC. (US) | 2019-11-12 | — | — | US | disclosed |
| US-6340772-B2 | AROMATIZATION OF CYCLOHEXENONE DERIVATIVES VIA (CHLORO)CYCLOHEXADIENE | NIPPON KAYAKU CO., LTD. (JP) | 2002-01-22 | — | — | US | disclosed |
| US-20010020112-A1 | Process for preparing (hetero) aromatic substituted benzene derivatives | TOYA TETSUYA (JP) | 2001-09-06 | — | — | US | disclosed |
| US-6271418-B1 | AROMATIZATION OF CYCLOHEXENONE DERIVATIVES VIA (CHLORO)CYCLOHEXADIENE DERIVATIVES. | NIPPON KAYAKU CO., LTD. (JP) | 2001-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010020112-A1 | Process for preparing (hetero) aromatic substituted benzene derivatives | AHR, CYP3A4, CYP4B1 | ALDH1A1 1596/4885HPGD 451/4885CYP1A2 8/4885 |
| US-10472313-B1 | Process for synthesizing trifluoroketones | FRK, PFKFB2, PFKFB1 | ALDH1A1 1615/4885HPGD 3685/4885CYP1A2 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.